AR222685A1 - Un procedimiento para la preparacion de espiro-(imidazolidin-4,4'-pirano 3,2-h)o(2,3-f)quinolin)-2,5-dionas - Google Patents

Un procedimiento para la preparacion de espiro-(imidazolidin-4,4'-pirano 3,2-h)o(2,3-f)quinolin)-2,5-dionas

Info

Publication number
AR222685A1
AR222685A1 AR279683A AR27968380A AR222685A1 AR 222685 A1 AR222685 A1 AR 222685A1 AR 279683 A AR279683 A AR 279683A AR 27968380 A AR27968380 A AR 27968380A AR 222685 A1 AR222685 A1 AR 222685A1
Authority
AR
Argentina
Prior art keywords
dionas
spyro
pyrane
imidazolidin
quinolin
Prior art date
Application number
AR279683A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR222685A1 publication Critical patent/AR222685A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR279683A 1979-01-22 1980-01-18 Un procedimiento para la preparacion de espiro-(imidazolidin-4,4'-pirano 3,2-h)o(2,3-f)quinolin)-2,5-dionas AR222685A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,278 US4176185A (en) 1979-01-22 1979-01-22 Spiro-quinolylhydantoins

Publications (1)

Publication Number Publication Date
AR222685A1 true AR222685A1 (es) 1981-06-15

Family

ID=21715098

Family Applications (1)

Application Number Title Priority Date Filing Date
AR279683A AR222685A1 (es) 1979-01-22 1980-01-18 Un procedimiento para la preparacion de espiro-(imidazolidin-4,4'-pirano 3,2-h)o(2,3-f)quinolin)-2,5-dionas

Country Status (22)

Country Link
US (1) US4176185A (es)
EP (1) EP0014079B1 (es)
JP (1) JPS5840959B2 (es)
KR (1) KR830001940A (es)
AR (1) AR222685A1 (es)
AT (1) AT365588B (es)
AU (1) AU514271B2 (es)
CA (1) CA1140928A (es)
DE (1) DE3060079D1 (es)
DK (1) DK156399C (es)
EG (1) EG15085A (es)
ES (1) ES487923A0 (es)
FI (1) FI69308C (es)
GR (1) GR72408B (es)
IE (1) IE49365B1 (es)
IL (1) IL59177A (es)
NO (1) NO152172C (es)
NZ (1) NZ192650A (es)
PH (1) PH15472A (es)
PT (1) PT70716A (es)
YU (1) YU41692B (es)
ZA (1) ZA80344B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
ATE10940T1 (de) * 1981-05-12 1985-01-15 Imperial Chemical Industries Plc Pyrrolderivate.
WO1989001775A1 (en) * 1987-09-04 1989-03-09 Pfizer Inc. Azolidinedione derivatives
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3876659A (en) * 1970-09-18 1975-04-08 Sandoz Ag Spiro tricyclic isoindolines
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins

Also Published As

Publication number Publication date
JPS5840959B2 (ja) 1983-09-08
NZ192650A (en) 1984-04-27
AU5476680A (en) 1980-07-31
NO152172B (no) 1985-05-06
EG15085A (en) 1986-12-30
IE49365B1 (en) 1985-09-18
DK156399B (da) 1989-08-14
FI69308B (fi) 1985-09-30
US4176185A (en) 1979-11-27
YU41692B (en) 1987-12-31
ES8103090A1 (es) 1981-02-16
NO794318L (no) 1980-07-23
GR72408B (es) 1983-11-02
PH15472A (en) 1983-01-24
KR830001940A (ko) 1983-05-19
JPS55108873A (en) 1980-08-21
IL59177A (en) 1982-11-30
ATA26780A (de) 1981-06-15
YU13180A (en) 1983-01-21
PT70716A (en) 1980-02-01
ZA80344B (en) 1981-02-25
FI800163A (fi) 1980-07-23
AU514271B2 (en) 1981-01-29
DK156399C (da) 1990-01-08
AT365588B (de) 1982-01-25
IL59177A0 (en) 1980-05-30
DK24280A (da) 1980-07-23
EP0014079B1 (en) 1981-11-18
IE800109L (en) 1980-07-22
EP0014079A1 (en) 1980-08-06
NO152172C (no) 1985-08-14
ES487923A0 (es) 1981-02-16
FI69308C (fi) 1986-01-10
CA1140928A (en) 1983-02-08
DE3060079D1 (en) 1982-01-21

Similar Documents

Publication Publication Date Title
ES496442A0 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina
ES497304A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilamino-fluorano.
ES487843A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
AR227288A1 (es) Un procedimiento para la preparacion de derivados de 2,3-difenil-5-(trifluormetiltio o trifuormetilsulfonil)-tiofeno
ES488886A0 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES496019A0 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
ES490722A0 (es) Un procedimiento para la preparacion de nuevos derivados de piridazina.
ES498017A0 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES490290A0 (es) Un procedimiento para la preparacion de derivados de tioxan tina.
ES496486A0 (es) Un procedimiento para la preparacion de nuevos 1,2,4-triazo-les
AR222685A1 (es) Un procedimiento para la preparacion de espiro-(imidazolidin-4,4'-pirano 3,2-h)o(2,3-f)quinolin)-2,5-dionas
ES495589A0 (es) Un procedimiento para la preparacion de derivados de imida- lol.
ES491238A0 (es) Un procedimiento para la preparacion de pirido (1,2-a) piri-midinas substituidas
ES491683A0 (es) Procedimiento para la preparacion de 1,3,7-trialquilxantinas
ES497530A0 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ES495932A0 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
ES492115A0 (es) Un procedimiento para la preparacion de 10, 11-dihidro-5-h- dibenzo (a,d) ciclohepten -5,10-iminas
ES494130A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoxocina.
ES508293A0 (es) "procedimiento para la preparacion de derivados de tiazolina".
ES501213A0 (es) Procedimiento para la preparacion de derivados de 2,3,4,5- tetrahidro-1-benzoxepin-3,5-diona
ES508152A0 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
AR224342A1 (es) Un procedimiento para la preparacion de derivados 4'-desoxi-leurosidina o 4'-desoxi-vlb
ES497209A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina